Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2 or NRF2) - Overview
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2 or NRF2) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2 or NRF2) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2 or NRF2) - Companies Involved in Therapeutics Development
AKL Research and Development Ltd
Annji Pharmaceutical Co Ltd
Anteris Bio
Arbor Pharmaceuticals LLC
Bach Pharma Inc
Bayer AG
BioApex sro
Biogen Inc
Biotoxtech Co Ltd
C4X Discovery Holdings Plc
Cellix Bio Pvt Ltd
Complexa Inc
Cureveda LLC
Daiichi Sankyo Co Ltd
Erganeo
Evgen Pharma Plc
Haisco Pharmaceutical Group Co Ltd
Immungenetics AG
Ixchel Pharma LLC
Ligmed LLC
Mariposa Therapeutics Ltd
Mochida Pharmaceutical Co Ltd
Reata Pharmaceuticals Inc
Rescue Therapeutics Inc
Scohia Pharma Inc
Sulfateq BV
Vitalis LLC
Vividion Therapeutics Inc
vTv Therapeutics Inc
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2 or NRF2) - Drug Profiles
(apocynin + paeonol) - Drug Profile
Product Description
Mechanism Of Action
History of Events
(aspirin + dimethyl fumarate) - Drug Profile
Product Description
Mechanism Of Action
History of Events
(aspirin + diroximel fumarate) - Drug Profile
Product Description
Mechanism Of Action
History of Events
(aspirin + monomethyl fumarate) - Drug Profile
Product Description
Mechanism Of Action
History of Events
ALZ-001 - Drug Profile
Product Description
Mechanism Of Action
History of Events
ALZ-002 - Drug Profile
Product Description
Mechanism Of Action
History of Events
BA-1521 - Drug Profile
Product Description
Mechanism Of Action
bardoxolone methyl - Drug Profile
Product Description
Mechanism Of Action
History of Events
BTT-105 - Drug Profile
Product Description
Mechanism Of Action
History of Events
C4X-6746 - Drug Profile
Product Description
Mechanism Of Action
History of Events
CLXNEU-06 - Drug Profile
Product Description
Mechanism Of Action
CXA-10 - Drug Profile
Product Description
Mechanism Of Action
History of Events
DH-404 - Drug Profile
Product Description
Mechanism Of Action
dimethyl fumarate - Drug Profile
Product Description
Mechanism Of Action
History of Events
dimethyl fumarate - Drug Profile
Product Description
Mechanism Of Action
History of Events
dimethyl fumarate DR - Drug Profile
Product Description
Mechanism Of Action
History of Events
diroximel fumarate DR - Drug Profile
Product Description
Mechanism Of Action
History of Events
HPP-3033 - Drug Profile
Product Description
Mechanism Of Action
History of Events
HPP-971 - Drug Profile
Product Description
Mechanism Of Action
History of Events
HSK-36212 - Drug Profile
Product Description
Mechanism Of Action
History of Events
HYCO-13 - Drug Profile
Product Description
Mechanism Of Action
History of Events
IXC-103 - Drug Profile
Product Description
Mechanism Of Action
History of Events
LGM-2605 - Drug Profile
Product Description
Mechanism Of Action
History of Events
MG-132 - Drug Profile
Product Description
Mechanism Of Action
MIND-4 - Drug Profile
Product Description
Mechanism Of Action
History of Events
monosodium luminol - Drug Profile
Product Description
Mechanism Of Action
History of Events
nifurtimox - Drug Profile
Product Description
Mechanism Of Action
History of Events
omaveloxolone - Drug Profile
Product Description
Mechanism Of Action
History of Events
RS-9 - Drug Profile
Product Description
Mechanism Of Action
History of Events
RTI-79 - Drug Profile
Product Description
Mechanism Of Action
History of Events
SCO-116 - Drug Profile
Product Description
Mechanism Of Action
SFX-01 - Drug Profile
Product Description
Mechanism Of Action
History of Events
SFX-02 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Small Molecule to Activate NFE2L2 for Central Nervous System, Metabolic Disorders, Cardiovascular and Ophthalmology - Drug Profile
Product Description
Mechanism Of Action
History of Events
Small Molecule to Activate NFE2L2 for Neurodegenerative Diseases - Drug Profile
Product Description
Mechanism Of Action
History of Events
Small Molecules to Activate NFE2L2 for Oncology - Drug Profile
Product Description
Mechanism Of Action
History of Events
Small Molecules to Activate NRF2 for Chronic Kidney Disease and Inflammatory Bowel Disease - Drug Profile
Product Description
Mechanism Of Action
History of Events
Small Molecules to Inhibit Nrf2 for Epidermolysis Bullosa - Drug Profile
Product Description
Mechanism Of Action
History of Events
Small Molecules to Target GSK3B and Nrf2 for Alzheimer’s Disease - Drug Profile
Product Description
Mechanism Of Action
SUL-121 - Drug Profile
Product Description
Mechanism Of Action
TBE-31 - Drug Profile
Product Description
Mechanism Of Action
tepilamide fumarate - Drug Profile
Product Description
Mechanism Of Action
History of Events
TFM-735 - Drug Profile
Product Description
Mechanism Of Action
VCB-102 - Drug Profile
Product Description
Mechanism Of Action
VEDA-1209 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2 or NRF2) - Dormant Products
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2 or NRF2) - Discontinued Products
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2 or NRF2) - Product Development Milestones
Featured News & Press Releases
Apr 04, 2022: Biogen announces new update on VUMERITY at AAN 2022
Mar 31, 2022: Reata Pharmaceuticals completes rolling submission of new drug application for Omaveloxolone for the treatment of patients with Friedreich?s Ataxia
Mar 17, 2022: Viatris defeats Biogen’s attempt to Revive Tecfidera patent
Mar 07, 2022: Evgen Pharma : Expansion of collaboration with the Manchester Breast Centre
Feb 25, 2022: Reata Pharmaceuticals receives complete response letter from the FDA for bardoxolone for the treatment of patients with chronic kidney disease caused by Alport syndrome
Feb 15, 2022: Haisco’s announcement on obtaining the "Notice of Acceptance" for clinical trial application of innovative drug HSK36212 capsules
Jan 31, 2022: Reata Pharmaceuticals initiates rolling submission of new drug application with U.S. FDA for Omaveloxolone for the treatment of patients with Friedreich?s ataxia
Jan 11, 2022: Evgen Pharma: Progress with UK and US regulators for 2022 clinical trials
Dec 14, 2021: Imara presents preclinical data on IMR-261 at the American Society of Hematology (ASH) Annual Meeting 2021
Dec 08, 2021: Reata Pharmaceuticals announces outcome of FDA advisory committee meeting of Bardoxolone for the treatment of patients with chronic kidney disease caused by alport syndrome
Dec 08, 2021: Reata Pharmaceuticals stock trading halted; FDA Advisory Committee to discuss bardoxolone for the treatment of patients with chronic kidney disease caused by Alport Syndrome
Dec 01, 2021: Viatris wins Federal circuit court appeal upholding district court decision invalidating Biogen’s Tecfidera Patent
Nov 18, 2021: Reata Pharmaceuticals receives Fast Track Desigtion from the FDA for Omaveloxolone for the treatment of Friedreich?s Ataxia
Nov 16, 2021: The European Commission grants marketing authorization for VUMERITY (diroximel fumarate) as oral treatment for relapsing-remitting multiple sclerosis
Nov 10, 2021: Evgen Pharma: Publication of data on SFX-01 in glioblastoma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development by Stage of Development, 2022
Number of Products under Development by Therapy Areas, 2022
Number of Products under Development by Top 10 Indications, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development by Stage of Development, 2022
Number of Products under Development by Therapy Areas, 2022
Number of Products under Development by Indications, 2022
Number of Products under Development by Companies, 2022
Products under Development by Companies, 2022
Number of Products under Investigation by Universities/Institutes, 2022
Products under Investigation by Universities/Institutes, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Pipeline by AKL Research and Development Ltd, 2022
Pipeline by Annji Pharmaceutical Co Ltd, 2022
Pipeline by Anteris Bio, 2022
Pipeline by Arbor Pharmaceuticals LLC, 2022
Pipeline by Bach Pharma Inc, 2022
Pipeline by Bayer AG, 2022
Pipeline by BioApex sro, 2022
Pipeline by Biogen Inc, 2022
Pipeline by Biotoxtech Co Ltd, 2022
Pipeline by C4X Discovery Holdings Plc, 2022
Pipeline by Cellix Bio Pvt Ltd, 2022
Pipeline by Complexa Inc, 2022
Pipeline by Cureveda LLC, 2022
Pipeline by Daiichi Sankyo Co Ltd, 2022
Pipeline by Erganeo, 2022
Pipeline by Evgen Pharma Plc, 2022
Pipeline by Haisco Pharmaceutical Group Co Ltd, 2022
Pipeline by Immungenetics AG, 2022
Pipeline by Ixchel Pharma LLC, 2022
Pipeline by Lignamed LLC, 2022
Pipeline by Mariposa Therapeutics Ltd, 2022
Pipeline by Mochida Pharmaceutical Co Ltd, 2022
Pipeline by Reata Pharmaceuticals Inc, 2022
Pipeline by Rescue Therapeutics Inc, 2022
Pipeline by Scohia Pharma Inc, 2022
Pipeline by Sulfateq BV, 2022
Pipeline by Vitalis LLC, 2022
Pipeline by Vividion Therapeutics Inc, 2022
Pipeline by vTv Therapeutics Inc, 2022
Dormant Products, 2022
Discontinued Products, 2022